Russian Journal of Genetics

, Volume 38, Issue 2, pp 213–215 | Cite as

Frequencies of the CCR2-64I and SDF1-3"A Alleles Associated with Progression of the HIV-1 Disease in Healthy Individuals from Moscow

  • G. S. Ryabov
  • E. V. Kazennova
  • A. F. Bobkov


The frequencies of two mutations associated with the development of clinical symptoms upon infection with human immunodeficiency virus type 1 (HIV-1) were determined in a cohort of individuals from Moscow. Allelic frequency of the first mutation, CC2-64I, causing the substitution of valine with isoleucine in the CCR2 chemokine receptor, was 0.1106 (95% confidence interval, 0.0714–0.1498). The frequency of the second mutation, the G to A substitution in the 3"-untranslated region of the stromal-derived factor 1 encoding gene, SDF1- 3"A, was 0.2125 (95% confidential interval, 0.1608–0.2642). Both values were slightly higher than those obtained earlier for Western European countries. This result can be explained by higher proportion of migrants from Asian regions, characterized by higher frequencies of these mutations, in the population of Moscow.


Confidence Interval Human Immunodeficiency Virus Allelic Frequency European Country Clinical Symptom 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Smith, M.W., Dean, M., Carrington, M., et al., Contrast ing Genetic Influence of CCR2 and CCR5 Variants on HIV-1 Infection and Disease Progression, Science, 1997, vol. 277, pp. 959-965.Google Scholar
  2. 2.
    Winkler, C., Modi, W., Smith, M.W., et al., Genetic Restriction of AIDS Pathogenesis by and SDF-1 Chemokine Gene Variant, Science, 1998, vol. 279, pp. 389-393.Google Scholar
  3. 3.
    Nookhai, S., Ruxrungtham, K., Phanuphak, P., and Oelrichs, R., Prevalence of CCR2-64I, SDF1-3'A, and CCR-5-?32 Alleles in Healthy Thais, Eur. J. Immuno-genet., 2000, vol. 27, pp. 153-157.Google Scholar
  4. 4.
    Williamson, C., Loubser, S.A., Brice, B., et al., Allelic Frequencies of Host Genetic Variants Influencing Susceptibility to HIV-1 Infection and Disease in South African Populations, AIDS, 2000, vol. 14, pp. 449-451.Google Scholar
  5. 5.
    Voevodin, A., Samilchuk, E., and Dashti, S., Frequencies of SDF-1 Chemokine, CCR-5, and CCR-2 Chemokine Receptor Gene Alleles Conferring Resistance to Human Immunodeficiency Virus Type 1 and AIDS in Kuwaitis, J. Med. Virol., 1999, vol. 58, pp. 54-58.Google Scholar
  6. 6.
    Romano-Spica, V., Ianni, A., Arzani, D., et al., Allelic Distribution of CCR5 and CCR2 Genes in an Italian Population Sample, AIDS Res. Hum. Retroviruses, 2000, vol. 16, pp. 99-101.Google Scholar
  7. 7.
    Struyf, F., Thoelen, I., Charlier, N., et al., Prevalence of CCR5 and CCR2 HIV-Coreceptor Gene Polymorphisms in Belgium, Hum. Hered., 2000, vol. 50, pp. 304-307.Google Scholar
  8. 8.
    Eugen-Olsen, J., Iversen, A.K., Benfield, T.L., et al., Chemokine Receptor CCR2b-64I Polymorphism and Its Relation to CD4 T-Cell Counts and Disease Progression in a Danish Cohort of HIV-Infected Individuals: CopenhagenAIDS Cohort, Acquir. Immune. Defic. Syndr. Hum. Retvirol., 1998, vol. 18, pp. 110-116.Google Scholar
  9. 9.
    Kazennova, E.V., Aarons, E., Selimova, L.M., et al., Comparative Analysis of the Distribution of the Mutant Allele of the Chemokine Receptor CCR-5 Gene in Individuals Infected and Noninfected by HIV-1 in Russia, Vopr. Virusol., 1998, vol. 43, no. 1, pp. 30-32.Google Scholar
  10. 10.
    Magierowska, M., Theodorou, I., Debre, P., et al., Combined Genotypes of CCR5, CCR2, SDF1, and HLA Genes Can Predict the Long-Term Nonprogressor Status in Human Immunodeficiency Virus-1-Infected Individuals, Blood, 1999, vol. 93, pp. 936-941.Google Scholar
  11. 11.
    Mellado, M., Rodriguez-Frade, J.M., Vila-Coro, A.J., et al., Chemokine Control of HIV-1 Infection, Nature, 1999, vol. 400, pp. 723-724.Google Scholar
  12. 12.
    Arya, S.K., Ginsberg, C.C., Davis-Warren, A., and D'Costa, J., In vitro Phenotype of SDF1 Gene Mutant That Delays the Onset of Human Immunodeficiency Virus Disease in Vivo, J. Hum. Virol., 1999, vol. 2, pp. 133-138.Google Scholar
  13. 13.
    Michael, N.L., Lougie, L.G., Rohrbaugh, A.L., et al., The Role of CCR5 and CCR2 Polymorphisms in HIV-1 Transmission and Disease Progression, Nat. Med., 1997, vol. 3, pp. 1150-1162.Google Scholar
  14. 14.
    Schinkel, J., Langendam, M.W., Coutinho, R.A., et al., No Evidence for an Effect of the CCR5-delta32/+ and CCR2b-64I/+ Mutations on Human Immunodeficiency Virus (HIV) 1 Disease Progression among HIV-1-Infected Injecting Drug Users, J. Infect. Dis., 1999, vol. 179, pp. 825-831.Google Scholar
  15. 15.
    van Rij, R.P., Broersen, S., Goudsmit, J., et al., The Role of a Stromal Cell-Derived Factor-1 Chemokine Gene Variant in the Clinical Course of HIV-1 Infection, AIDS, 1998, vol. 12, pp. F85-F90.Google Scholar
  16. 16.
    Bobkov, A., Kazenova, E., Khanina, T., et al., An HIV Type 1 Subtype A Strain of Low Genetics Diversity Continues to Spread among Injecting Drug Users in Russia: Study of New Local Outbreaks in Moscow and Irkutsk, AIDS Res. Hum. Retroviruses, 2001, vol. 17, pp. 257-261.Google Scholar

Copyright information

© MAIK “Nauka/Interperiodica” 2002

Authors and Affiliations

  • G. S. Ryabov
    • 1
  • E. V. Kazennova
    • 1
  • A. F. Bobkov
    • 1
  1. 1.Ivanovsky Institute of VirologyRussian Academy of Medical SciencesMoscowRussia

Personalised recommendations